Facet Wealth Inc’s AbbVie ABBV Stock Holding History

Facet Wealth Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.81M	Sell	11,184 -231	-2%	-$49.7K	0.04%	76
2026 Q1	$2.48M	Buy	11,415 +6,376	+127%	+$1.41M	0.04%	72
2025 Q4	$1.1M	Buy	5,039 +1,256	+33%	+$286K	0.02%	96
2025 Q3	$876K	Buy	3,783 +216	+6%	+$44K	0.02%	90
2025 Q2	$674K	Buy	3,567 +1,086	+44%	+$202K	0.02%	87
2025 Q1	$486K	Buy	2,481 +83	+3%	+$16.1K	0.01%	87
2024 Q4	$457K	Sell	2,398 -41	-2%	-$7.54K	0.01%	92
2024 Q3	$496K	Buy	2,439 +742	+44%	+$138K	0.01%	90
2024 Q2	$317K	Sell	1,697 -76	-4%	-$12.6K	0.01%	102
2024 Q1	$289K	Buy	1,773 +326	+23%	+$56.2K	0.01%	94
2023 Q4	$251K	Buy	+1,447	New	+$211K	0.01%	97
2023 Q3	–	Sell	-1,754	Closed	-$262K	–	96
2023 Q2	$262K	Buy	1,754 +104	+6%	+$15.3K	0.01%	80
2023 Q1	$263K	Sell	1,650 -13	-0.8%	-$1.99K	0.02%	64
2022 Q4	$253K	Buy	1,663 +30	+2%	+$4.6K	0.02%	61
2022 Q3	$242K	Buy	+1,633	New	+$234K	0.02%	59

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Facet Wealth Inc's ABBV Position: Q2 2026 in Review

Facet Wealth Inc reduced its AbbVie (ABBV) stake by 2% in Q2 2026, selling an estimated $49.7K and leaving 11,184 shares worth $2.81M. The position accounts for 0.04% of the portfolio, ranked #76.

Facet Wealth Inc first reported a position in ABBV in Q3 2022 and has held it in 15 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Facet Wealth Inc held 11,184 shares of AbbVie worth $2.81M as of Q2 2026.
Facet Wealth Inc sold 231 AbbVie shares in Q2 2026, an estimated $49.7K.
AbbVie made up 0.04% of Facet Wealth Inc's portfolio in Q2 2026, its #76 holding.
Facet Wealth Inc first reported a position in AbbVie in Q3 2022 and has held it in 15 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Facet Wealth Inc's 13F filing for Q2 2026, filed 27 Jul 2026.